Follow WOWNEWS 24x7 on:
Marksans Pharma’s UK subsidiary, Relonchem Limited, has received MHRA authorization to market Cetirizine, a popular antihistamine. The approval strengthens its generics portfolio in Europe, ensuring steady demand and enhancing regulatory credibility. Analysts see this as a growth driver, reinforcing Marksans’ global expansion strategy in affordable healthcare solutions.
Show moreStay Ahead – Explore Now! Bajel Projects Secures 132kV Transmission Line EPC Contract in Bhopal
Follow WOWNEWS 24x7 on:
Copyright 2024 WOWNEWS 24x7. All rights reserved. The WOWNEWS 24x7 is not responsible for the content of external sites. Read about our approach to external linking.
Powered By Just Imagine
